HR 6412

The Independence Investment Fund Act establishes a new fund within the Department of the Treasury to invest in U.S.-based companies developing critical and emerging technologies, particularly in biotechnology. The fund aims to bolster national and economic security by supporting innovation and providing an alternative source of funding for companies vulnerable to foreign investment. It will be overseen by a supervisory board and advisory board, comprised of experts, to guide its investments and ensure alignment with national security priorities. The fund will operate through an independent managing entity and seek to generate financial returns while prioritizing investments in biotechnology.